You are here: Industry Insights > RDIF

News List

RDIF announces Sputnik V efficacy data from San Marino ExpressPharma
November 26, 2021
The Russian Direct Investment Fund (RDIF) yesterday announced new positive real-world data of the Ministry of Health of the Republic of San Marino on efficacy of the Russian Sputnik V vaccine...
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effecti prnasia
October 15, 2021
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the interim results of the study in Argentina on heterogeneous regimens combining Sputnik Light ...
AstraZeneca and Sputnik V combination show no adverse events: RFID expresspharma
August 02, 2021
The world’s first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination.
Sputnik V vaccine production in India to go fully on stream in September: RDIF firstwordpharma
August 02, 2021
The Russian Direct Investment Fund (RDIF) said that production of the Sputnik V COVID-19 vaccine in India is expected to start in September, The Economic Times reported Sunday.
First batches of the Sputnik V vaccine produced in Uzbekistan by Jurabek Laboratories firstwordpharma
August 02, 2021
RDIF, Russia's sovereign wealth fund, and one of the leading pharmaceutical companies of Uzbekistan, Jurabek Laboratories, today announced the first batches of the Russian Sputnik vaccine against coronavirus have been produced at company's facilities.
Serum Institute to start manufacturing Sputnik vaccine in September expresspharma
July 14, 2021
The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September, RDIF said.
SII to commence manufacturing of Sputnik COVID-19 vaccine in September expresspharma
July 14, 2021
As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year.
RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India expresspharma
July 07, 2021
The Russian Direct Investment Fund (RDIF) and Morepen Laboratories announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in the state of Himachal Pradesh (HP).
RDIF: Test batch of the Sputnik V vaccine produced in Mexico firstwordpharma
July 06, 2021
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) and Mexican pharmaceutical company Laboratorios de Biológicos y Reactivos de México (BIRMEX) announce the production of a test batch of the Russian Sputnik V vaccine against corona
RDIF: Sputnik V has demonstrated 97.8% efficacy against COVID cases and 100% efficacy against severe cases of COVID in UAE prnewswire
June 30, 2021
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the data of UAE's Ministry of Health on the Russian Sputnik V coronavirus vaccine confirming its safety and high efficacy during the vaccination campaign.

Previous page 1 2 3 4 5 Next page